MASHINIi

HeartSciences Inc..

HSCS.US | Manufacture of irradiation, electromedical and electrotherapeutic equipment

HeartSciences Inc. is a medical technology company focused on advancing electrocardiography through the application of machine learning. Their MyoVista® wavECG™ is a 12-lead resting electrocardiograph that provides diagnostic information related to cardiac dysfunction. The company's technology aims ...Show More

Ethical Profile

Mixed.

HeartSciences Inc. demonstrates a strong commitment to improving cardiac health through its AI-enhanced ECG technology. Their MyoVista AI-ECG model, trained on over 120,000 ECG records, reportedly increased the odds of flagging high-risk patients by 21% in a 1461-patient clinical trial. The FDA granted Breakthrough Device designation for their AS ECG algorithm, aiming for earlier aortic stenosis detection. The MyoVista® wavECG™ could potentially reduce LV function test queries by 49.5%, improving cardiovascular pathway efficiency and accessibility. However, reports suggest insufficient evidence to assess the company's performance in areas like fair pay, ethical sourcing, or planet-friendly business practices.

Value Scores

Better Health for All20
-100100
Fair Money & Economic Opportunity0
-100100
Fair Pay & Worker Respect0
-100100
Fair Trade & Ethical Sourcing0
-100100
Honest & Fair Business-50
-100100
Kind to Animals0
-100100
No War, No Weapons0
-100100
Planet-Friendly Business0
-100100
Respect for Cultures & Communities0
-100100
Safe & Smart Tech-20
-100100
Zero Waste & Sustainable Products0
-100100

Better Health for All

20

HeartSciences' core business is dedicated to developing AI-powered ECG technology for the early detection of various cardiac dysfunctions, including LV dysfunction, asymptomatic heart disease, and aortic stenosis. This focus on early diagnosis aims to improve patient outcomes, prevent irreversible myocardial damage, and shift care towards preventative measures, with 100% of its portfolio delivering revolutionary health benefits.

1
The FDA granted Breakthrough Device designation for its AI-ECG algorithm for detecting aortic stenosis in June 2025, and the Innovation Value Institute selected MyoVista as a technology to radically transform healthcare.
2
The company's products are diagnostic tools, with no evidence of negative health outcomes.
3
HeartSciences has invested in the development of these AI-ECG solutions, with an algorithm trained on over 120,000 ECG records.
4
The company completed a pivotal study with over 600 patients across 5 centers in the US, which commenced in 2021, and received FDA confirmation to change its clearance pathway to a standard 510(k) submission, with anticipated clearance in 2024.
5
The MyoVista is positioned as a low-cost point-of-care device, and its AI-ECG algorithm is designed for seamless integration with existing hospital EHR systems, potentially increasing accessibility and expanding access to early diagnosis in underserved areas.
6
However, no specific pricing data or quantitative reach to vulnerable populations is provided. The company's focus on early detection directly supports preventative health measures.

Fair Money & Economic Opportunity

0

HeartSciences Inc. is a medical technology company focused on developing AI-powered ECG solutions for heart disease detection.

1
Its core business involves medical devices and software, not financial services.
2
As such, the company does not engage in activities related to lending, insuring, moving, or storing money for consumers.
3
Therefore, all KPIs under the 'Fair Money & Economic Opportunity' value, which are designed for financial institutions, are not applicable to HeartSciences Inc.'s operations.

Fair Pay & Worker Respect

0

No evidence available to assess HeartSciences Inc. on Fair Pay & Worker Respect.

Fair Trade & Ethical Sourcing

0

No data relevant to Fair Trade & Ethical Sourcing for HeartSciences Inc. (HSCS.US) could be extracted from the provided articles.

1
Both articles explicitly state that they do not contain any information pertaining to the company's fair trade certifications, supply chain audits, labor practices, traceability, remediation processes, ethical clauses in contracts, materials risk, or supplier diversity spend.
2

Honest & Fair Business

-50

The Audit Committee establishes procedures for employees to anonymously submit concerns about questionable accounting or other matters, and the nominating and corporate governance committee provides oversight over whistleblower matters.

1
However, there is no evidence of independent investigation processes for these concerns. The company is required to comply with the Foreign Corrupt Practices Act (FCPA), which generally prohibits bribery, but the article does not detail the policy's training frequency or effectiveness metrics.
2
The FDA generally conducts a preapproval inspection of the applicant or its third-party manufacturers’ or suppliers’ manufacturing facility or facilities to ensure compliance with Quality System Regulations (QSR), indicating some third-party verification for manufacturing facilities, but the extent of verification for broader ethical claims is not specified.
3

Kind to Animals

0

No evidence available to assess HeartSciences Inc. on Kind to Animals.

No War, No Weapons

0

HeartSciences Inc. is a medical technology company focused on advancing electrocardiography through the application of machine learning, developing AI-based ECG analysis tools and a 12-lead resting electrocardiograph.

1
The company's core business is entirely within medical diagnostics, with no evidence of involvement in weapons, defense, or military-related activities. There is no indication of revenue from arms or defense contracts, no development or sale of dual-use technologies, and no military applications for its AI systems.
2
The company's operations do not require ethical red lines related to weapons, nor does it have any exposure to controversial weapons. No information is available regarding the company's investment ratio in peace technology versus military technology, but its core business is exclusively medical.
3

Planet-Friendly Business

0

The provided articles do not contain any specific, concrete data points related to environmental, social, and governance (ESG) metrics or planet-friendly business practices for HeartSciences Inc. One article explicitly states that sustainability data is currently unavailable for the company, and another notes the absence of information on ESG metrics relevant to planet-friendly business practices.

1

Respect for Cultures & Communities

0

No evidence available to assess HeartSciences Inc. on Respect for Cultures & Communities.

Safe & Smart Tech

-20

The company's AWS infrastructure ensures HIPAA compliance, which is a basic required certification for the industry.

1
Its privacy policy also states a commitment to complying with legal obligations.
2
For sensitive information, such as credit card numbers, SSL encryption is employed.
3
Users are provided with basic data control options, specifically the ability to opt-out of newsletters and promotional communications.
4

Zero Waste & Sustainable Products

0

No evidence available to assess HeartSciences Inc. on Zero Waste & Sustainable Products.

Own HeartSciences Inc.?

Upload your portfolio and see how all your holdings score across 11 ethical dimensions.

Audit My Portfolio

AI-generated analysis based on publicly available data. Not financial advice. Ratings are expressions of opinion derived from automated models and may contain inaccuracies. See our Risk Disclosure for full details.